Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Other Operating Expenses: 2021-2025

Historic Other Operating Expenses for InMed Pharmaceuticals (INM) over the last 5 years, with Sep 2025 value amounting to $110,196.

  • InMed Pharmaceuticals' Other Operating Expenses rose 408.21% to $110,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $279,619, marking a year-over-year increase of 579.68%. This contributed to the annual value of $191,106 for FY2025, which is 166.99% up from last year.
  • According to the latest figures from Q3 2025, InMed Pharmaceuticals' Other Operating Expenses is $110,196, which was up 498.60% from $18,409 recorded in Q2 2025.
  • InMed Pharmaceuticals' Other Operating Expenses' 5-year high stood at $145,839 during Q3 2022, with a 5-year trough of -$8.8 million in Q2 2022.
  • In the last 3 years, InMed Pharmaceuticals' Other Operating Expenses had a median value of $62,268 in 2025 and averaged $46,835.
  • Examining YoY changes over the last 5 years, InMed Pharmaceuticals' Other Operating Expenses showed a top increase of 448.39% in 2024 and a maximum decrease of 133.60% in 2024.
  • Over the past 5 years, InMed Pharmaceuticals' Other Operating Expenses (MRQ) stood at -$2.9 million in 2021, then soared by 98.46% to -$44,315 in 2022, then surged by 34.47% to -$29,040 in 2023, then soared by 405.60% to $88,746 in 2024, then increased by 24.17% to $110,196 in 2025.
  • Its last three reported values are $110,196 in Q3 2025, $18,409 for Q2 2025, and $62,268 during Q1 2025.